Inventor · disambiguated record
Wayne C. Schairer
Also filed as: SCHAIRER WAYNE · SCHAIRER WAYNE C · SCHAIRER WAYNE CARL
11 granted patents·12 pending applications·51 citations·filing 2000–2025
87Inventor score
Top patents by PatentIndex Score
23 records- 0194US11708361B2Processes and intermediates for the preparation of soluble guanylate cyclase stimulatorsCYCLERION THERAPEUTICS INC·Filed 2021·Granted Jul 25, 2023·2 cites·14 claims
- 0293US12030874B2Processes and intermediates for the preparation of soluble guanylate cyclase stimulatorsCYCLERION THERAPEUTICS INC·Filed 2023·Granted Jul 9, 2024·1 cites·20 claims
- 0387US12275724B2Processes and intermediates for the preparation of soluble guanylate cyclase stimulatorsCYCLERION THERAPEUTICS INC·Filed 2024·Granted Apr 15, 2025·0 cites·4 claims
- 0487US11274096B2Processes and intermediates for the preparation of soluble guanylate cyclase stimulatorsCYCLERION THERAPEUTICS INC·Filed 2019·Granted Mar 15, 2022·2 cites·22 claims
- 0582US12247025B2Processes for preparation of soluble guanylate cyclase stimulatorsCYCLERION THERAPEUTICS INC·Filed 2023·Granted Mar 11, 2025·0 cites·3 claims
- 0681US11834444B2Processes for preparation of soluble guanylate cyclase stimulatorsCYCLERION THERAPEUTICS INC·Filed 2017·Granted Dec 5, 2023·2 cites·18 claims
- 0781US7320972B24-Biarylyl-1-phenylazetidin-2-onesMICROBIA INC·Filed 2004·Granted Jan 22, 2008·24 cites·71 claims
- 0880US8884020B2Indole compoundsTALLEY JOHN JEFFREY·Filed 2007·Granted Nov 11, 2014·11 cites·18 claims
- 0979US2025361228A1Processes and intermediates for the preparation of soluble guanylate cyclase stimulatorsCYCLERION THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1076US8455497B2Inhibitors of aspartyl proteaseHALE MICHAEL R·Filed 2009·Granted Jun 4, 2013·2 cites·40 claims
- 1172US6878728B1Inhibitors of aspartyl proteaseVERTEX PHARMA·Filed 2000·Granted Apr 12, 2005·7 cites·20 claims
- 1264US8426359B2Inhibitors of serine proteases, particularly HCV NS3-NS4A proteaseCOTTRELL KEVIN M·Filed 2008·Granted Apr 23, 2013·0 cites·6 claims
- 1356US2005119189A1Inhibitors of serine proteases, particularly HCV NS3-NS4A proteaseFiled 2004·Application pending·0 cites
- 1455US2013316945A1Inhibitors of serine proteases, particularly hcv ns3-ns4a proteaseVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 1551US2008167255A14-biarylyl-1-phenylazetidin-2-onesMICROBIA INC·Filed 2007·Application pending·0 cites
- 1647US2004122000A1Inhibitors of aspartyl proteaseVERTEX PHARMA·Filed 2003·Application pending·0 cites
- 1745US2008200669A1Processes For Production of Phenolic 4-Biphenylylazetidin-2-OnesMICROBIA INC·Filed 2006·Application pending·0 cites
- 1842US2008287663A1Process For Production Of 4-Biphenylyazetidin-2-OnesMICROBIA INC·Filed 2006·Application pending·0 cites
- 1939US2009292135A1Organometal benzenephosphonate coupling agentsIRONWOOD PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2039US2009131395A1Biphenylazetidinone cholesterol absorption inhibitorsMICROBIA INC·Filed 2006·Application pending·0 cites
- 2139US2009099355A1Processes for Production of 4-(Biphenylyl)Azetidin-2-One Phosphonic AcidsMICROBIA INC·Filed 2006·Application pending·0 cites
- 2236US2013178453A1Cannabinoid AgonistsROHDE JASON·Filed 2011·Application pending·0 cites
- 2332US2014187795A1Crth2 modulators and preparation thereofJIA JAMES·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wayne C. Schairer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →